A Double-Blind, Randomized, Multicenter Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures.

Trial Profile

A Double-Blind, Randomized, Multicenter Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2014

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Partial epilepsies
  • Focus Registrational; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 04 Dec 2012 Results presented at the 66th Annual Meeting of the American Epilepsy Society.
    • 22 Feb 2012 Status of the extension trial is completed (EudraCT2009-016850-42).
    • 22 Feb 2012 Status of the extension trial is completed (EudraCT2009-016850-42).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top